相关实验视频

Updated: Jun 5, 2025

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

获得对PD-L1抑制的耐药性增强了瘤中的I型IFN调节的分泌程序

Yuhao Shi¹, Amber McKenery², Melissa Dolan¹

¹Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.

|December 11, 2024

概括

获得对PD-L1 (编程细胞死亡连接体1) 的耐药性抑制通过I型干扰素 (IFN) 重新连接瘤细胞分泌. 这种改变的瘤机密体抑制T细胞激活,阻碍抗瘤免疫力,促进免疫逃避.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
分子瘤学分子瘤学

背景情况:

治疗性PD-L1抑制调节抗瘤免疫力.
瘤细胞可以对免疫检查点抑制剂产生抵抗力.
干扰素 (IFN) 信号影响瘤细胞分泌和免疫反应.

研究的目的:

研究瘤细胞中IFN调节的分泌变化,这些瘤细胞对PD-L1抑制产生抵抗力.
描述导致对PD-L1阻塞产生抗性的瘤内在适应.
了解瘤细胞秘密体如何在获得抵抗期间影响抗瘤免疫力.

主要方法:

开发具有对抗PD-L1疗法的获得性耐药性的瘤模型.
通过抗PD-L1治疗 (PTIS) 诱导的瘤分泌物的分析.
评估PTIS对T细胞活化和瘤细胞细胞毒性的影响.
在体内研究涉及对具有破坏PTIS组件或IFN信号的耐药瘤进行重新植入.

主要成果:

在耐药瘤中确定了一种由I型IFN调节的抗PD-L1治疗诱导分泌体 (PTIS).
证明PTIS抑制T细胞活化ex vivo并减少瘤细胞细胞毒性.
表明阻断PTIS组件或I型IFN信号 in vivo会减缓或停止耐药瘤的生长.
观察到体外PD-L1干扰仅部分模仿PTIS表型,强调需要体内耐药性模型.

结论:

获得对PD-L1抑制的耐药性涉及瘤细胞分泌程序的重新连接.
I型IFN是这种抗性相关分泌体的关键调节者.
PTIS赋予瘤外部免疫抑制作用,保护瘤免受免疫攻击.
在体内模型对于准确研究临床相关的治疗失败机制至关重要.

关键词:

国际货币基金组织 IFN IFN 免疫检查点检查点在PD-L1中.电阻电阻电阻电阻电阻电阻一个秘密,一个秘密.

更多相关视频

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...